Director, Federal Government Affairs- Senate HELP Republican at Bristol-Myers Squibb

Washington, District of Columbia, United States

Apply Now

Not SpecifiedCompensation

Senior (5 to 8 years), Expert & Leadership (9+ years)Experience Level

Full TimeJob Type

UnknownVisa

Pharmaceuticals, Healthcare, Government AffairsIndustries

Requirements

A minimum of 8 years of experience/service on Capitol Hill or relevant private sector professional experience
Excellent verbal, analytical, written and interpersonal communication skills, particularly in interpreting and distilling complex information
Excellent organizational and project management skills—demonstrated ability to independently manage multiple work streams
Experience working with a variety of stakeholders, including trade associations and coalitions, and ability to proactively drive consensus
Ability to maintain good working relationships, internally and externally
Travel as required

Responsibilities

Represent BMS before the U.S. Congress, primarily with Senate Republicans on company specific issues as well as issues of importance to the pharmaceutical industry
Collaborate with internal business partners to ensure an aligned approach and pursuit of Enterprise goals and priorities
Cultivate and maintain relationships with Members of Congress and their staff that will distinguish the company as a leader in the biopharmaceutical space while proactively advancing company objectives
Navigate the legislative and political environment and create (and implement) comprehensive strategies to address regulatory, legislative and policy issues that may impact BMS
Engage with external groups, including trade associations, to influence internal decisions and ensure alignment with BMS goals and priorities
Execute tactics around the company’s Political Action Committee focused on political giving strategy and internal growth
Provide updates and presentations to internal colleagues on developments in Washington, DC
Manage federal engagement by BMS consultants
Additional duties as necessary to support USPGA

Skills

Federal Government Affairs

Health Care Policy

Legislative Strategy

Congressional Outreach

Senate HELP Committee

Policy Analysis

Stakeholder Engagement

Pharmaceutical Policy

Government Relations

Bristol-Myers Squibb

Develops and delivers biopharmaceutical medicines

About Bristol-Myers Squibb

Bristol Myers Squibb (BMS) develops and delivers medicines aimed at treating serious diseases, focusing on areas like cancer, autoimmune diseases, and heart conditions. The company conducts extensive research and development to create new drugs, which are sold after receiving regulatory approval. BMS also produces generic drugs, offering affordable alternatives that meet the same quality standards as their branded counterparts. What sets BMS apart from competitors is its dual focus on both innovative and generic medicines, enhancing access to healthcare. The company's goal is to improve patient outcomes while maintaining a commitment to sustainability and corporate responsibility.

New York City, New YorkHeadquarters

1887Year Founded

$33,706.1MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Benefits

Flexible Work Hours

Hybrid Work Options

Professional Development Budget

Risks

Increased competition in oncology from emerging biotech firms like ArsenalBio.

BMS's lawsuit over the 340B Drug Pricing Program may lead to regulatory challenges.

Rapid AI and digital tech evolution may pose integration challenges for BMS.

Differentiation

BMS focuses on innovative cancer treatments through collaborations like ArsenalBio for T cell therapies.

The company emphasizes digital health technologies, enhancing clinical trial management and patient engagement.

BMS offers both innovative and generic medicines, increasing affordable healthcare solutions.

Upsides

BMS's partnership with Medidata enhances clinical research processes and patient outcomes.

The collaboration with AI Proteins advances novel miniprotein-based therapeutics, expanding therapeutic modalities.

BMS's global license agreement with BioArctic expands its portfolio in neurodegenerative diseases.

Land your dream remote job 3x faster with AI

Try Jobo Free